✦ LIBER ✦

Interpreting clinical trials of diabetic dyslipidaemia: new insights

✍ Scribed by A. S. Wierzbicki

Book ID: 109044526
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 112 KB
Volume: 11
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2007.00751.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Coronary disease, dyslipidaemia and clin

Coronary disease, dyslipidaemia and clinical trials in type 2 diabetes mellitus

✍ Watts, Gerald F. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Endoplasmic reticulum stress in diabetes

Endoplasmic reticulum stress in diabetes: New insights of clinical relevance

✍ Muthuswamy Balasubramanyam; Raji Lenin; Finny Monickaraj 📂 Article 📅 2010 🏛 Association of Clinical Biochemistry of India 🌐 English ⚖ 301 KB

Controversy in the interpretation of cli

Controversy in the interpretation of clinical trials

✍ Prof P. Armitage 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views

New insights into clinical trial for col

New insights into clinical trial for colostrinin™ in Alzheimer’s disease

✍ P. Szaniszlo; P. German; G. Hajas; D. N. Saenz; M. Kruzel; I. Boldogh 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 308 KB

The design of clinical trials for treatm

The design of clinical trials for treatment of diabetic neuropathy

✍ Dan Ziegler 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 733 KB

Interpreting the results of Parkinson's

Interpreting the results of Parkinson's disease clinical trials: Time for a change

✍ Nick H. G. Holford; John G. Nutt 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views

## Abstract Randomized clinical trials testing putative disease‐modifying agents in Parkinson's disease (PD) have yielded controversial results that have not influenced evidence‐based recommendations for the treatment of PD. We argue that the failure of these clinical trials may be linked to end po